Peculiarities of L-DOPA treatment of Parkinson’s disease

@article{Kostrzewa2005PeculiaritiesOL,
  title={Peculiarities of L-DOPA treatment of Parkinson’s disease},
  author={R. Kostrzewa and P. Nowak and J. P. Kostrzewa and R. A. Kostrzewa and R. Brus},
  journal={Amino Acids},
  year={2005},
  volume={28},
  pages={157-164}
}
  • R. Kostrzewa, P. Nowak, +2 authors R. Brus
  • Published 2005
  • Medicine, Biology
  • Amino Acids
  • Summary.L-Dihydroxyphenylalanine (L-DOPA), the anti-parkinsonian drug affording the greatest symptomatic relief of parkinsonian symptoms, is still misunderstood in terms of its neurotoxic potential and the mechanism by which generated dopamine (DA) is able to exert an effect despite the absence of DA innervation of target sites in basal ganglia. This review summaries important aspects and new developments on these themes. On the basis of L-DOPA therapy in animal models of Parkinson’s disease… CONTINUE READING
    Biosynthesis of matrix vesicles in epiphyseal cartilage
    27
    Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation
    73

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 47 REFERENCES
    Transgressive character expression in a hybrid sunflower species.
    135
    A retrospective analysis of pituitary apoplexy.
    300
    Low Physical Activity Accentuates the Effect of the FTO rs9939609 Polymorphism on Body Fat Accumulation
    475